aceneuramic acid April 12, 2017 aceneuramic acid Trade Name Orphan Indication Hereditary inclusion body myopathy USA Market Approval USA USA Designation Date 2011-09-23 00:00:00 Sponsor Ultragenyx Pharmaceutical, Inc.;60 Leveroni Court, Suite 200;Novato, California, 94949
